These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6368400)

  • 41. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 42. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis.
    Babeş VT; Tănase M; Cepănaru S; Cepănaru R
    Virologie; 1981; 32(2):93-8. PubMed ID: 6787796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radioimmunoassay for the detection of HBeAg and anti-HBe.
    Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Incidence of HBeAg in hemodialysis patients: preliminary data (author's transl)].
    Toti M; Alegente G; Almi P; Rubino M; Marini M; Facchini C
    Ann Sclavo; 1980; 22(3):455-8. PubMed ID: 7247498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of the HBe system in an area highly endemic for hepatitis B virus.
    Del Vecchio-Blanco C; Caporaso N; Balzano A; Ambrogio G; Aldershvile J; Juhl E; Nielsen JO
    Infection; 1983; 11(1):13-6. PubMed ID: 6840863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
    Calzia R; Ciravegna B; Navone C; Tolentino P
    Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
    Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
    Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Frequency and prognostic value of the "e" system in hepatitis B virus infection].
    Onesciuc C; Onesciuc I; Jebeleanu L; Serban I; Gorgan V; Cîrstina D; Oprean N; Feticu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(3):175-8. PubMed ID: 7433816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study.
    Suzuki H; Yamamoto S; Hirayama C; Takino T; Fujisawa K; Oda T
    Liver; 1986 Feb; 6(1):35-44. PubMed ID: 3520204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathological changes between HBeAg and anti-HBe in patients with chronic hepatitis B].
    Xu Q; Shu X; Chen L; Zhou Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Dec; 9(6):340-2. PubMed ID: 11782300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infectivity in asymptomatic hepatitis B carriers: its correlation with HBeAg/anti-HBe status.
    Cheng NY; Chang JG; Liao ST; Liu JD; Lee LS; Chen PH; Choo KB
    Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):148-51. PubMed ID: 2769214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 57. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatitis B virus DNA. Detection with polymerase chain reaction in liver tissue of children with chronic hepatitis B].
    Wirth S; Schaefer E; Winterpacht A; Zabel B
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):759-62. PubMed ID: 1435797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.